{"id":"W1992527377","doi":"10.1016/j.pharmthera.2004.10.005","title":"Emerging role of cyclic ADP-ribose (cADPR) in smooth muscle","year":2004,"lang":"en","type":"review","venue":"Pharmacology & Therapeutics","topic":"Calcium signaling and nucleotide metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; Heart and Stroke Foundation of British Columbia and Yukon; National Institute of General Medical Sciences; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Canada","keywords":"Ryanodine receptor; Cyclic ADP-ribose; Second messenger system; Intracellular; Inositol; Cell biology; Inositol trisphosphate; Cyclic adenosine monophosphate; Inositol trisphosphate receptor; Receptor; Signal transduction; Biology; Chemistry; Biochemistry; CD38","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003533785,0.0004862219,0.001195755,0.0002420762,0.00005474314,0.00001048099,0.000528471,0.0005828924,0.00009165453],"category_scores_gemma":[0.000006912976,0.000461909,0.0005232826,0.0003104957,0.0001767146,0.000003659994,0.0001849674,0.0005283903,0.00002321991],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005544849,"about_ca_system_score_gemma":0.0003615275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000367366,"about_ca_topic_score_gemma":0.000009147406,"domain_scores_codex":[0.9976829,0.0003421209,0.0007509977,0.0005695814,0.0001508838,0.0005035225],"domain_scores_gemma":[0.9989757,0.00005144349,0.0004197317,0.0003944715,0.00006613928,0.0000925485],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004755351,0.0003258712,0.00001498994,0.001874326,0.0006506399,0.0000131575,0.0001332413,0.0000720317,0.1610225,0.00002963597,0.0001330666,0.835683],"study_design_scores_gemma":[0.0007804002,0.0000989923,0.00001837155,0.0006058505,0.001559634,0.00001179125,0.00002262185,0.00001096903,0.01015925,0.00008092627,0.9862464,0.0004048066],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005724785,0.9926773,0.00002507528,0.00005424798,0.0007545457,0.0004809118,0.00006395987,0.00002195087,0.0001972325],"genre_scores_gemma":[0.005310821,0.9929482,0.0001244707,0.0004990864,0.0006858027,0.00007691271,0.0001543816,0.0001125929,0.00008768764],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9861133,"threshold_uncertainty_score":0.9997833,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03067189346650085,"score_gpt":0.3590100019686581,"score_spread":0.3283381085021572,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}